What’s new at CHBRP? FEATURED Jul 5, 2023 Status of 2023 Bills Analyzed by CHBRP As bills move through the Legislature, bills may be significantly amended, which may alter CHBRP’s projected impacts. CHBRP maintains a record of the extent to which CHBRP’s analyses remain relevant as the bills move through the Legislative process. Feb 20, 2024 CHBRP has received a request to analyze AB 3245 (Patterson): Colorectal Cancer Screening. Feb 20, 2024 CHBRP has received a request to analyze AB 2180 (Weber): Cost Sharing Feb 16, 2024 CHBRP has received a request to analyze AB 2843 (Petrie-Norris): Rape and sexual assault. Feb 16, 2024 CHBRP has received a request to analyze AB 3059 (Weber): Human Milk. Feb 16, 2024 CHBRP has received a request to analyze SB 1008 (Bradford): Obesity Treatment Parity Act. Feb 15, 2024 CHBRP has received a request to analyze AB 2668 (Berman): Coverage for cranial prostheses. Feb 15, 2024 CHBRP has received a request to analyze SB 1180 (Ashby): emergency medical services. Feb 15, 2024 CHBRP has received a request to analyze AB 2028 (Ortega): Medical loss ratios. Jan 12, 2024 CHBRP newly published an infographic for the analysis of SB 839 Obesity Treatment Parity Act Dec 22, 2023 CHBRP has completed its analysis of SB 839 Obesity Treatment Parity Act Oct 11, 2023 CHBRP has completed an analysis of Prior Authorization in California at the request of the Legislature Jul 5, 2023 Status of 2023 Bills Analyzed by CHBRP Jun 9, 2023 CHBRP has completed its analysis of SB 635 (Menjivar and Portantino): Hearing Aids May 16, 2023 CHBRP has received a request to analyze SB 839 (Bradford): Obesity Treatment Parity Act May 11, 2023 CHBRP has received a request from the Legislature to prepare a report centered on the ways in which California-regulated healthcare service plans and health insurers are utilizing prior authorization. Apr 24, 2023 CHBRP has completed its analysis of AB 1060 (Ortega): Naloxone Hydrochloride Apr 24, 2023 CHBRP has completed its analysis of AB 1048 (Wicks): Dental Benefits and Rate Review Apr 24, 2023 CHBRP has completed its analysis of SB 427 (Portantino): Antiretroviral Drugs, Devices, and Products Apr 24, 2023 CHBRP has completed its analysis of SB 339 (Wiener): HIV Preexposure Prophylaxis and Postexposure Prophylaxis Apr 24, 2023 CHBRP has completed its analysis of AB 907 (Lowenthal): Coverage for PANDAS and PANS. Apr 24, 2023 CHBRP has completed its analysis of AB 1451 (Jackson): Behavioral Health Crisis Treatment Pagination Current page 1 Page 2 Page 3 Next page Next Last page Last